logo
Nearly 1 in 5 Healthcare Leaders Say Cyberattacks Have Impacted Patient Care, Omega Systems Report Finds

Nearly 1 in 5 Healthcare Leaders Say Cyberattacks Have Impacted Patient Care, Omega Systems Report Finds

Business Wire3 days ago

READING, Pa.--(BUSINESS WIRE)-- Omega Systems, a leading provider of managed IT and security services, today released new research that reveals the growing impact of cybersecurity challenges on leading healthcare organizations and patient safety. According to the 2025 Healthcare IT Landscape Report, 19% of healthcare leaders say a cyberattack has already disrupted patient care, and more than half (52%) believe a fatal cyber-related incident is inevitable within the next five years.
These concerns come as attacks become more widespread, frequent, and severe. In the past year, 80% of healthcare organizations were targeted by at least one cyberattack, with social engineering attacks (48%) and ransomware (34%) topping the list. Concerningly, more than 1 in 4 organizations reported that at least half of their sensitive patient data was at risk due to cyberattacks, and yet many teams admitted to relying on outdated infrastructure, manual processes, and limited in-house staffing to defend against modern threats.
'Healthcare is one of the most frequently targeted industries by cybercriminals – and not surprisingly given the sensitive data they manage. Unfortunately, growing gaps in cyber risk management are resulting in real-world consequences for patients and major setbacks for organizations,' said Mike Fuhrman, CEO of Omega Systems. 'The data shows that although leaders don't report cybersecurity as a top challenge, it's directly impacting their highest priorities – from patient safety to regulatory compliance. This disconnect is a growing risk across the healthcare industry that needs to be addressed with better visibility, readiness, and resources.'
While leaders report many significant challenges hindering their business success, cybersecurity ranks last (33%) – trailing behind other priorities such as rising operational costs (53%), maintaining compliance (52%), and protecting patient data (40%). Other key findings include:
Confidence in cyber readiness doesn't match reality: 80% of healthcare leaders are confident in their teams' ability to stop AI-powered cyberattacks. However, internal preparation tells a different story. Nearly a third of companies don't regularly train their employees on how to respond to cyber threats, and only 53% run phishing simulations. Nearly 1 in 5 lack a current or effective incident response plan, and almost 25% acknowledge it could take up to a month to detect and contain a data breach – with some sectors like life sciences taking even longer.
Outdated systems are weakening defenses: More than half (56%) of leaders say outdated infrastructure would delay breach recovery, and 36% admit their current cybersecurity tools cannot protect cloud-based patient data. Compounding the issue, most have yet to adopt advanced security tools like next-gen EDR with moving threat defense (only 46%) and data discovery technology (46%), and more than a third (34%) don't know what data is at risk across their network, making proactive defense nearly impossible.
Internal teams are stretched thin: Nearly two-thirds of healthcare organizations surveyed maintain an in-house IT or cybersecurity team, but 23% say they are understaffed. In the event of a cyberattack, 1 in 5 companies believe recovery would be delayed because they lack experienced in-house staff or access to a 24x7 security operations team.
Compliance is causing pressure: Though there is a general feeling of preparedness for upcoming HIPAA rule changes, 54% of companies surveyed still rely on manual in-house processes to handle compliance management. 60% say staying current with regulations is their top challenge, while 57% of organizations lack the time and resources to meet stringent requirements and oversee the compliance process.
Despite the increasingly sophisticated threat landscape, 55% of healthcare organizations are not currently partnered with a Managed Security Service Provider (MSSP) for added expertise and support. The data shows healthcare companies that co-manage IT and security with an MSSP are better equipped to handle rising threats and compliance demands, outperforming peers in areas like threat detection speed, vulnerability assessments, HIPAA control adoption, and managed compliance use.
'Healthcare teams are under immense pressure, and internal resources alone aren't enough to stay ahead of today's threats,' added Fuhrman. 'Leading organizations are leveraging MSSPs to gain a competitive advantage through advanced tools, continuous monitoring, and regulatory expertise for a new level of security. The end result is bottom-line protection in the healthcare sector - from patient safety and reputation, to financial growth and operational resilience.'
To download the full 2025 Healthcare IT Landscape Report, visit https://omegasystemscorp.com/insights/white-papers/2025-healthcare-it-landscape-report/.
About Omega Systems
As a trusted MSP and MSSP to heavily regulated industries including healthcare, Omega Systems is passionate about delivering the security and compliance expertise today's businesses need alongside the responsive and reliable managed IT support they deserve. Omega's service-driven IT solutions are designed to help customers leverage technology to fuel efficiencies, mitigate risk, and empower growth and success. We support that commitment by injecting trust, innovation and service excellence into every engagement – delivering a superior and satisfying customer experience unparalleled by other MSPs.
Learn more at www.omegasystemscorp.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA
Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA

Yahoo

time8 hours ago

  • Yahoo

Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA

All amounts in Canadian dollars unless specified otherwise SASKATOON, Saskatchewan, June 06, 2025--(BUSINESS WIRE)--Cameco (TSX: CCO; NYSE: CCJ) reports an expected increase of approximately $170 million (US) in our 49% equity share of Westinghouse Electric Company's (Westinghouse) 2025 second quarter and annual adjusted EBITDA. The expected increase is tied to Westinghouse's participation in the construction project for two nuclear reactors at the Dukovany power plant in the Czech Republic. This expected increase will be taken into consideration in determining the 2025 distribution payable by Westinghouse to Cameco. In addition to the increase in adjusted EBITDA in 2025, we expect significant financial benefits for Westinghouse, as a subcontractor, over the term of the Dukovany construction project and related to the provision of the fuel fabrication services required for both reactors for a specified period. The outlook for Westinghouse's compound annual growth rate for adjusted EBITDA remains 6% to 10% over the next five years, excluding the impact of the expected $170 million (US) increase in its 2025 adjusted EBITDA. Cameco owns a 49% interest in Westinghouse and its partner, Brookfield Renewable Partners, owns the remaining 51%. Caution about forward-looking informationThis news release includes statements and information about our expectations for the future, which we refer to as forward-looking information. Forward-looking information is based on our current views, which can change significantly, and actual results and events may be significantly different from what we currently expect. Examples of forward-looking information in this news release include our expectations regarding: Westinghouse's participation in the Dukovany power plant construction project; an increase in Westinghouse's adjusted EBITDA; Westinghouse taking this increase into consideration in determining the 2025 distribution payable to Cameco; the financial benefits for Westinghouse, as subcontractor, over the term of the Dukovany construction project and the expected future growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Material risks that could lead to different results include the risk that Westinghouse is not able to participate in the Dukovany construction project on a basis that achieves the currently expected benefits to Westinghouse for any reason, or that Cameco may not derive the expected increases in its share of Westinghouse's adjusted EBITDA, or that Westinghouse does not achieve the expected future annual growth in adjusted EBITDA. In presenting the forward-looking information, we have made material assumptions which may prove incorrect about Westinghouse's participation in the Dukovany construction project and related potential benefits to Westinghouse, and continuing growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Non-IFRS MeasuresAdjusted EBITDA is a measure that does not have a standardized meaning or a consistent basis of calculation under International Financial Reporting Standards (a non-IFRS measure). Westinghouse's adjusted EBITDA is defined as its net income, adjusted for the impact of certain expenses, costs, charges or benefits incurred in such period which are either not indicative of underlying business performance or that impact the ability to assess the operating performance of its business. For more information regarding our use of this non-IFRS measure see our most recent annual and quarterly Management's Discussion and Analysis. ProfileCameco is one of the largest global providers of the uranium fuel needed to power a secure energy future. Our competitive position is based on our controlling ownership of the world's largest high-grade reserves and low-cost operations, as well as significant investments across the nuclear fuel cycle, including ownership interests in Westinghouse Electric Company and Global Laser Enrichment. Utilities around the world rely on Cameco to provide global nuclear fuel solutions for the generation of safe, reliable, carbon-free nuclear power. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan, Canada. As used in this news release, the terms we, us, our, the Company and Cameco mean Cameco Corporation and its subsidiaries unless otherwise indicated. View source version on Contacts Investor inquiries Cory Kos 306-716-6782 cory_kos@ Media inquiries Veronica Baker 306-385-5541 veronica_baker@ Sign in to access your portfolio

Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA
Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA

Yahoo

time8 hours ago

  • Yahoo

Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA

All amounts in Canadian dollars unless specified otherwise SASKATOON, Saskatchewan, June 06, 2025--(BUSINESS WIRE)--Cameco (TSX: CCO; NYSE: CCJ) reports an expected increase of approximately $170 million (US) in our 49% equity share of Westinghouse Electric Company's (Westinghouse) 2025 second quarter and annual adjusted EBITDA. The expected increase is tied to Westinghouse's participation in the construction project for two nuclear reactors at the Dukovany power plant in the Czech Republic. This expected increase will be taken into consideration in determining the 2025 distribution payable by Westinghouse to Cameco. In addition to the increase in adjusted EBITDA in 2025, we expect significant financial benefits for Westinghouse, as a subcontractor, over the term of the Dukovany construction project and related to the provision of the fuel fabrication services required for both reactors for a specified period. The outlook for Westinghouse's compound annual growth rate for adjusted EBITDA remains 6% to 10% over the next five years, excluding the impact of the expected $170 million (US) increase in its 2025 adjusted EBITDA. Cameco owns a 49% interest in Westinghouse and its partner, Brookfield Renewable Partners, owns the remaining 51%. Caution about forward-looking informationThis news release includes statements and information about our expectations for the future, which we refer to as forward-looking information. Forward-looking information is based on our current views, which can change significantly, and actual results and events may be significantly different from what we currently expect. Examples of forward-looking information in this news release include our expectations regarding: Westinghouse's participation in the Dukovany power plant construction project; an increase in Westinghouse's adjusted EBITDA; Westinghouse taking this increase into consideration in determining the 2025 distribution payable to Cameco; the financial benefits for Westinghouse, as subcontractor, over the term of the Dukovany construction project and the expected future growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Material risks that could lead to different results include the risk that Westinghouse is not able to participate in the Dukovany construction project on a basis that achieves the currently expected benefits to Westinghouse for any reason, or that Cameco may not derive the expected increases in its share of Westinghouse's adjusted EBITDA, or that Westinghouse does not achieve the expected future annual growth in adjusted EBITDA. In presenting the forward-looking information, we have made material assumptions which may prove incorrect about Westinghouse's participation in the Dukovany construction project and related potential benefits to Westinghouse, and continuing growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Non-IFRS MeasuresAdjusted EBITDA is a measure that does not have a standardized meaning or a consistent basis of calculation under International Financial Reporting Standards (a non-IFRS measure). Westinghouse's adjusted EBITDA is defined as its net income, adjusted for the impact of certain expenses, costs, charges or benefits incurred in such period which are either not indicative of underlying business performance or that impact the ability to assess the operating performance of its business. For more information regarding our use of this non-IFRS measure see our most recent annual and quarterly Management's Discussion and Analysis. ProfileCameco is one of the largest global providers of the uranium fuel needed to power a secure energy future. Our competitive position is based on our controlling ownership of the world's largest high-grade reserves and low-cost operations, as well as significant investments across the nuclear fuel cycle, including ownership interests in Westinghouse Electric Company and Global Laser Enrichment. Utilities around the world rely on Cameco to provide global nuclear fuel solutions for the generation of safe, reliable, carbon-free nuclear power. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan, Canada. As used in this news release, the terms we, us, our, the Company and Cameco mean Cameco Corporation and its subsidiaries unless otherwise indicated. View source version on Contacts Investor inquiries Cory Kos 306-716-6782 cory_kos@ Media inquiries Veronica Baker 306-385-5541 veronica_baker@

Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA
Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA

Business Wire

time8 hours ago

  • Business Wire

Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA

SASKATOON, Saskatchewan--(BUSINESS WIRE)-- Cameco (TSX: CCO; NYSE: CCJ) reports an expected increase of approximately $170 million (US) in our 49% equity share of Westinghouse Electric Company's (Westinghouse) 2025 second quarter and annual adjusted EBITDA. The expected increase is tied to Westinghouse's participation in the construction project for two nuclear reactors at the Dukovany power plant in the Czech Republic. This expected increase will be taken into consideration in determining the 2025 distribution payable by Westinghouse to Cameco. In addition to the increase in adjusted EBITDA in 2025, we expect significant financial benefits for Westinghouse, as a subcontractor, over the term of the Dukovany construction project and related to the provision of the fuel fabrication services required for both reactors for a specified period. The outlook for Westinghouse's compound annual growth rate for adjusted EBITDA remains 6% to 10% over the next five years, excluding the impact of the expected $170 million (US) increase in its 2025 adjusted EBITDA. Cameco owns a 49% interest in Westinghouse and its partner, Brookfield Renewable Partners, owns the remaining 51%. Caution about forward-looking information This news release includes statements and information about our expectations for the future, which we refer to as forward-looking information. Forward-looking information is based on our current views, which can change significantly, and actual results and events may be significantly different from what we currently expect. Examples of forward-looking information in this news release include our expectations regarding: Westinghouse's participation in the Dukovany power plant construction project; an increase in Westinghouse's adjusted EBITDA; Westinghouse taking this increase into consideration in determining the 2025 distribution payable to Cameco; the financial benefits for Westinghouse, as subcontractor, over the term of the Dukovany construction project and the expected future growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Material risks that could lead to different results include the risk that Westinghouse is not able to participate in the Dukovany construction project on a basis that achieves the currently expected benefits to Westinghouse for any reason, or that Cameco may not derive the expected increases in its share of Westinghouse's adjusted EBITDA, or that Westinghouse does not achieve the expected future annual growth in adjusted EBITDA. In presenting the forward-looking information, we have made material assumptions which may prove incorrect about Westinghouse's participation in the Dukovany construction project and related potential benefits to Westinghouse, and continuing growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Non-IFRS Measures Adjusted EBITDA is a measure that does not have a standardized meaning or a consistent basis of calculation under International Financial Reporting Standards (a non-IFRS measure). Westinghouse's adjusted EBITDA is defined as its net income, adjusted for the impact of certain expenses, costs, charges or benefits incurred in such period which are either not indicative of underlying business performance or that impact the ability to assess the operating performance of its business. For more information regarding our use of this non-IFRS measure see our most recent annual and quarterly Management's Discussion and Analysis. Profile Cameco is one of the largest global providers of the uranium fuel needed to power a secure energy future. Our competitive position is based on our controlling ownership of the world's largest high-grade reserves and low-cost operations, as well as significant investments across the nuclear fuel cycle, including ownership interests in Westinghouse Electric Company and Global Laser Enrichment. Utilities around the world rely on Cameco to provide global nuclear fuel solutions for the generation of safe, reliable, carbon-free nuclear power. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan, Canada. As used in this news release, the terms we, us, our, the Company and Cameco mean Cameco Corporation and its subsidiaries unless otherwise indicated.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store